AI-generated summary
The authors reviewed about 100 articles from four databases on cell therapy and laser or light therapy for Parkinson's disease, focusing on motor function and dopaminergic cell effects. They report that both approaches appear useful and that combined use may improve symptoms, despite stated limitations.
- Studies included
- 100
- Who or what was studied
- Parkinson's disease
- Limits stated in the abstract
- The abstract notes that the included approaches have limitations but does not specify them, and the review's conclusions are not supported by a stated patient total or study-quality assessment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sbmu.ac.ir.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Laser, Low-level laser therapy, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.